Stephen Brand
24Patents
7h-index
54Co-inventors
72Inventor score
Filing activity: Dec 14, 1992 → Aug 3, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6613541B1 | Method for monitoring proteasome inhibitor drug action | Physics | 47 | Expired |
| US6271199A | Treatment of infarcts | Human Necessities | 33 | Expired |
| US5693617A | Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein | Human Necessities | 21 | Expired |
| US6992060B2 | Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5885956A | Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand | Chemistry; Metallurgy | 12 | Expired |
| US6288301A | Treatment for juvenile diabetes | Chemistry; Metallurgy | 10 | Expired |
| US6558952B1 | Treatment for diabetes | Human Necessities | 7 | Expired |
| US6878718B2 | Phenylalanine enamide derivatives | Chemistry; Metallurgy | 7 | Expired |
| US6835738B1 | Phenylalanine enamide derivatives | Human Necessities | 7 | Expired |
| US6872719B1 | Phenylalanine enamide derivatives | Human Necessities | 7 | Expired |
| US7122556B2 | Phenylalanine enamide derivatives | Chemistry; Metallurgy | 5 | Expired |
| US9156811B2 | N-myristoyl transferase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7560425B2 | Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes | Human Necessities | 3 | Expired |
| US7037504B2 | Epidermal growth factor protein and gene, and methods of use therefor | Human Necessities | 2 | Expired |
| US7501437B2 | Phenylalanine enamide derivatives | Chemistry; Metallurgy | 2 | Active |
| US7557130B2 | Bicyclic heteroaromatic alanines | Chemistry; Metallurgy | 2 | Expired |
| US7531549B2 | Phenylalanine enamide derivatives | Chemistry; Metallurgy | 1 | Active |
| US7476388B2 | Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligand | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7645770B2 | Phenylalanine enamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US10065965B2 | Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US10479792B2 | Compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8324204B2 | Fused thiophene derivatives as kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9828346B2 | N-myristoyl transferase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7786177B2 | Phenylalanine enamide derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.